[1]
X. Li, X. Yu, F. Xu, Q. Li, and X. Xu, “Study on Esculetin to reduce cardiotoxicity induced by Doxorubicin”, Nep. J. Cancer, vol. 5, no. 1, pp. 70–73, Sep. 2021, doi: 10.3126/njc.v5i1.41329.